Noblejas-López, M.d.M.;                     Gandullo-Sánchez, L.;                     Galán-Moya, E.M.;                     López-Rosa, R.;                     Tébar-GarcÃa, D.;                     Nieto-Jiménez, C.;                     Gómez-Juárez, M.;                     Burgos, M.;                     Pandiella, A.;                     Ocaña, A.    
        Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer. Int. J. Mol. Sci. 2022, 23, 5476.
    https://doi.org/10.3390/ijms23105476
    AMA Style
    
                                Noblejas-López MdM,                                 Gandullo-Sánchez L,                                 Galán-Moya EM,                                 López-Rosa R,                                 Tébar-GarcÃa D,                                 Nieto-Jiménez C,                                 Gómez-Juárez M,                                 Burgos M,                                 Pandiella A,                                 Ocaña A.        
                Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer. International Journal of Molecular Sciences. 2022; 23(10):5476.
        https://doi.org/10.3390/ijms23105476
    
    Chicago/Turabian Style
    
                                Noblejas-López, MarÃa del Mar,                                 LucÃa Gandullo-Sánchez,                                 Eva M. Galán-Moya,                                 Raquel López-Rosa,                                 David Tébar-GarcÃa,                                 Cristina Nieto-Jiménez,                                 Mónica Gómez-Juárez,                                 Miguel Burgos,                                 Atanasio Pandiella,                                 and Alberto Ocaña.        
                2022. "Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer" International Journal of Molecular Sciences 23, no. 10: 5476.
        https://doi.org/10.3390/ijms23105476
    
    APA Style
    
                                Noblejas-López, M. d. M.,                                 Gandullo-Sánchez, L.,                                 Galán-Moya, E. M.,                                 López-Rosa, R.,                                 Tébar-GarcÃa, D.,                                 Nieto-Jiménez, C.,                                 Gómez-Juárez, M.,                                 Burgos, M.,                                 Pandiella, A.,                                 & Ocaña, A.        
        
        (2022). Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer. International Journal of Molecular Sciences, 23(10), 5476.
        https://doi.org/10.3390/ijms23105476